Could This Tiny Nuclear Company Power the Future of Data and AI?
NuScale Power (NYSE: SMR) isn’t your typical energy company. It’s a trailblazing player in nuclear innovation, aiming to rewrite how the world generates clean, consistent power. Rather than betting on sprawling, billion-dollar nuclear facilities, NuScale is going small, really small, with its modular reactors, designed to be trucked in and switched on as needed.
It sounds futuristic.
» Read more about: Could This Tiny Nuclear Company Power the Future of Data and AI? »
Read More
Will This Titan Be The Biggest Winner of the AI Revolution?
For decades, Oracle was considered something of a tech stalwart, respected, reliable, and, frankly, a little boring. Known for its dominance in database management, Oracle’s steady performance made it a favorite among conservative investors, but rarely the centerpiece of high-growth conversations.
That’s changing, and fast. Thanks to a massive shift in enterprise computing driven by artificial intelligence Oracle is no longer just a database company.
» Read more about: Will This Titan Be The Biggest Winner of the AI Revolution? »
Read More
1 Massive Advantage Retail Investors Have Over Hedge Funds
Retail investors are usually playing catch-up and it’s no surprise why. They don’t have a research department, a Bloomberg Terminal on every desk, or a network of analysts and insiders feeding them information in real time. Hedge funds, with their armies of research analysts, data scientists, and software systems, are optimized to gain any edge possible.
» Read more about: 1 Massive Advantage Retail Investors Have Over Hedge Funds »
Read More
Forget Tesla, This EV Stock Just Got a Billion-Dollar Lifeline
If you’ve spent any time watching the electric vehicle space, chances are you’ve already dug into Tesla. But as Tesla enters its next phase of maturity, investors with an eye for disruption might want to turn their attention to a different name, one that’s flying under the radar but could be setting up for a breakout.
» Read more about: Forget Tesla, This EV Stock Just Got a Billion-Dollar Lifeline »
Read More
1 Massive Advantage Retail Investors Have Over Hedge Funds
Retail investors are usually playing catch-up and it’s no surprise why. They don’t have a research department, a Bloomberg Terminal on every desk, or a network of analysts and insiders feeding them information in real time. Hedge funds, with their armies of research analysts, data scientists, and software systems, are optimized to gain any edge possible.
» Read more about: 1 Massive Advantage Retail Investors Have Over Hedge Funds »
Read MoreThe Ivy
Why This Dividend Growth ETF Might Be a Smarter Play Than Chasing High Yields
When it comes to generating passive income, it’s easy to fall for the lure of high-yield dividend stocks but there’s often a catch with those eye-popping yields. Sometime, they signal companies that have maxed out their growth potential and are simply returning excess cash because they don’t have better places to put it.
That’s why seasoned investors sometimes prefer a different route,
» Read more about: Why This Dividend Growth ETF Might Be a Smarter Play Than Chasing High Yields »
Read MoreThe Spotlight
Is Coca-Cola The #1 Stock During the Next Market Meltdown?
The recent market rebound feels more like a shaky truce than a confident comeback. Sure, stocks have climbed back from bear territory since April, but between persistent inflation and rising geopolitical tensions (hello, Middle East), the whole thing still feels like a house of cards.
So what do you do if you’re worried the next leg down is coming?
» Read more about: Is Coca-Cola The #1 Stock During the Next Market Meltdown? »
Read MoreThe Daily
Dow Jones Top Company Headlines at 3 AM ET: UBS Launches Buyback of Up to $2 Billion | Avadel …
UBS Launches Buyback of Up to $2 Billion
The buyback program delivers on UBS’s plans to hand money back to shareholders after the Swiss government proposed tougher capital rules for the bank earlier this month.
—-
Avadel Shareholder Seeks Ousting Drugmaker’s Entire Board
ASL Strategic Value Fund wants the narcolepsy drugmaker to retain investment bankers and consider a sale.